Publications by authors named "Matthew Hardee"

Claim this Profile
M
Medical Students' Diagnostic Accuracy and Treatment Plans.
Neal R Chamberlain, Patricia S Sexton, Matthew R Hardee, Robert W Baer

Mo Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician-Mentored Patient Rounds to Observe and Assess Entrustable Professional Activities 1 and 2 in Preclinical Medical Students.
Neal R Chamberlain, Patricia S Sexton, Matthew R Hardee, Robert W Baer

J Am Osteopath Assoc· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric effect on pediatric conformal treatment plans using dynamic jaw with Tomotherapy HDA.
Eun Young Han, Dong-Wook Kim, Xin Zhang, Jose Penagaricano, Xiaoying Liang, Matthew Hardee

Med Dosim· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia.
Nathan A Koonce, Joseph Levy, Matthew E Hardee, Azemat Jamshidi-Parsian, Kieng B Vang

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.
Nathan A Koonce, Charles M Quick, Matthew E Hardee, Azemat Jamshidi-Parsian, Judith A Dent

Int J Radiat Oncol Biol Phys· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Cutaneous Rosai-Dorfman Disease with underlying calvarial involvement and absence of BRAF mutation.
Nadine M Kaskas, Malan Kern, Andrew Johnson, Matthew P Hughes, Matthew Hardee

JAAD Case Rep· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β).
Ilenia Pellicciotta, Ariel E Marciscano, Matthew E Hardee, Derek Francis, Silvia Formenti

Growth Factors· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of phase II ablation after breast lumpectomy added to extend intraoperative margins (ABLATE l) trial.
V Suzanne Klimberg, Daniela Ochoa, Ronda Henry-Tillman, Matthew Hardee, Cristiano Boneti

J Am Coll Surg· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel Cell Carcinoma: Epidemiology, Target, and Therapy.
Mathew P Hughes, Matthew E Hardee, Lynn A Cornelius, Laura F Hutchins, Jurgen C Becker

Curr Dermatol Rep· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nipple skin-sparing mastectomy is feasible for advanced disease.
Eric C Burdge, James Yuen, Matthew Hardee, Pranjali V Gadgil, Chandan Das

Ann Surg Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of glioma-associated neovascularization.
Matthew E Hardee, David Zagzag

Am J Pathol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Matthew E Hardee, Ariel E Marciscano, Christina M Medina-Ramirez, David Zagzag, Ashwatha Narayana

Cancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide.
Matthew E Hardee, Silvia C Formenti

Front Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.
Matthew E Hardee, Shahzad Raza, Stewart J Becker, Gabor Jozsef, Stella C Lymberis

Int J Radiat Oncol Biol Phys· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous cell carcinoma of the prostate.
Rena D Malik, George Dakwar, Matthew E Hardee, Nicholas J Sanfilippo, Andrew B Rosenkrantz

Rev Urol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of high-risk localized prostate cancer.
Ariel E Marciscano, Matthew E Hardee, Nicholas Sanfilippo

Adv Urol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of chemoradiotherapy for high-risk prostate cancer.
Nicholas Sanfilippo, Matthew E Hardee, Jonathan Wallach

Rev Recent Clin Trials· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel imaging provides new insights into mechanisms of oxygen transport in tumors.
Matthew E Hardee, Mark W Dewhirst, Nikita Agarwal, Brian S Sorg

Curr Mol Med· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors.
Matthew E Hardee, Rose J Eapen, Zahid N Rabbani, Matthew R Dreher, Jeffrey Marks

Cancer Chemother Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors.
Brian S Sorg, Matthew E Hardee, Nikita Agarwal, Benjamin J Moeller, Mark W Dewhirst

J Biomed Opt· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
Matthew E Hardee, Yiting Cao, Ping Fu, Xiaohong Jiang, Yulin Zhao

PLoS One· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity.
Matthew E Hardee, Zahid N Rabbani, Murat O Arcasoy, John P Kirkpatrick, Zeljko Vujaskovic

Mol Cancer Ther· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinoma.
John P Kirkpatrick, Matthew E Hardee, Stacey A Snyder, Catherine M Peltz, Yulin Zhao

Radiat Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin biology in cancer.
Matthew E Hardee, Murat O Arcasoy, Kimberly L Blackwell, John P Kirkpatrick, Mark W Dewhirst

Clin Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis